The ongoing shortage of drugs, and especially small volume parenteral solutions, is causing changes in methods of drug administration. The King Guide® to Parenteral Admixtures® is designed to help practitioners decide which alternative administration strategy is best.
Switching to IV push, using solutions other than saline, using large volume solutions, or using syringe infusion pumps, may change the stability and compatibility characteristics of the medication to be administered. Fortunately, King® Guide, the oldest continuously published reference on parenteral drug stability and compatibility, is designed to provide practitioners with the timely information they need in this era of drug shortages.
The King® Guide
2019 marks the 48th year that the King Guide to Parenteral Admixtures has been the leading source of the most up-to-date IV drug compatibility and stability information in hospital pharmacy practice worldwide. In those 48 years, Dr. James King and Dr. Patrick Catania have been the only editors of the King Guide and have made carefully crafted updates every quarter using painstaking and time-tested methods for data collection and reporting. No other references can claim this kind of consistency in information compilation.
Drug safety, improved patient outcomes, ensuring compliance and eliminating costly errors have always been our top priorities. Using the latest technology and a consistent editorial team benefits practitioners' ability to analyze continuously updated information without sacrificing convenience and mobility.
At King Guide, we believe everyone is entitled to know exactly what new and updated information goes into our reference. No other injectable drug compatibility reference on the market offers this level of transparency, making it difficult to determine the quantity and quality of the work they produce.In 2018, we added...
4 New Drugs
New Compatibility Information for 341 Drugs
New Stability Information for 25 Drugs
A complete list of our updates is available on our news & updates page.
We invite you to compare "What's In Your Database?" and offer a free trial for your analysis.
We strive to include in the King Guide to Parenteral Admixtures only that information which has been published in peer reviewed and refereed journals or information that is provided by the manufacturer. We believe that by using only data that have been reviewed via the professional literature, we insure the accuracy of the content of King Guide. Unpublished results that have not had the benefit of scholarly review are inadequate and other references that rely heavily on unpublished results should be scrutinized cautiously.
System wide access to our database makes decision making available where it's needed most - at the point of care. We invite you to take a look for yourself by requesting a free trial.
JCAHO endorsed, our wall charts are ideal for nurses stations and are available in laminate for extra durability.
The original King Guide and still the best way to maintain rapidly changing information in print. Popular in facilities where technology isn't always available or when an offline resource is required.
For HIT vendors and hospitals. Add significant value to existing systems by incorporating the King Guide Database.
In this update we added new drug monographs for DAUNORUBICIN CITRATE LIPOSOME, IRINOTECAN LIPOSOME, PROTHROMBIN COMPLEX CONCENTRATE (HUMAN), and TRABECTEDIN.
We added new stability information for the existing drug monographs for ACYCLOVIR, AZACITIDINE, CALCIUM GLUCONATE, CEFUROXIME SODIUM, COLISTIMETHATE, DANTROLENE SODIUM, EDROPHONIUM CHLORIDE, ENOXAPARIN SODIUM, GANCICLOVIR SODIUM, LINCOMYCIN HYDROCHLORIDE, LINEZOLID, MEROPENEM, MINOCYCLINE HYDROCHLORIDE, PENTAMIDINE ISETHIONATE, PLERIXAFOR, and PROPOFOL.
In addition, new compatibility information is reported for these existing monographs: ANIDULAFUNGIN, CALCIUM GLUCONATE, CEFEPIME, DILTIAZEM, FLUCONAZOLE, FOSCARNET, LINEZOLID, MAGNESIUM SULFATE, MINOCYCLINE HYDROCHLORIDE, MORPHINE SULFATE, PENTAMIDINE ISETHIONATE, PERITONEAL DIALYSIS SOLUTIONS, POTASSIUM CHLORIDE, PROPOFOL, ROPIVACAINE, TIGECYCLINE, ZICONOTIDE, and ZIDOVUDINE.